Insight

Published within

« | ... | 352 | 353 | 354 | 355 | 356 | 357 | 358 | 359 | 360 | ... | » »|

Type Product title / description Pub Price
Report
Report

Nycomed A/S: PharmaVitae Report

Analysis of Nycomed's corporate strategy, marketed portfolio, pipeline potential and financial position in 2010 and to 2016

Published By Datamonitor
01 Jul 2011 $2800
Buy
Case Studies
Case Studies

Brazilian Orange Juice Case Study: Seizing Opportunities for Market Development in the Brazilian Orange Sector

This case study examines the reasons why consumers are replacing orange juice with other drink types and what strategies need to be adopted by the industry in Brazil to boost opportunities in the category both locally and in the international market.

Published By MarketLine
01 Jul 2011 $495
Buy
Case Studies
Case Studies

Aperol Case Study: Aligning an Authentic Italian Alcohol Brand with Contemporary Consumer Needs

This case study examines how the Aperol brand has achieved strong resonance among a geographically widening range of consumers despite its focus on the premium and on-trade aspects of the alcohol market in the middle of the global economic downturn.

Published By MarketLine
01 Jul 2011 $495
Buy
Case Studies
Case Studies

Regional Theme Case Study: Creating Distinction Through Leveraging Regional Differences

Assess how CPG companies are creating food and beverage products with a regional theme to appeal to consumers on both local and wider-reaching fronts.

Published By MarketLine
01 Jul 2011 $495
Buy
Report
Report

Johnson & Johnson: PharmaVitae Report

Analysis of Johnson & Johnson's corporate strategy, marketed portfolio, pipeline potential and financial position in 2010 and to 2016

Published By Datamonitor
30 Jun 2011 $2800
Buy
Report
Report

Merck & Co., Inc.: PharmaVitae Report

Analysis of Merck & Co.'s corporate strategy, marketed portfolio, pipeline potential and financial position in 2010 and to 2016

Published By Datamonitor
29 Jun 2011 $2800
Buy
Report
Report

Turkey: Pharmaceutical Industry Infrastructure Overview

This report provides an overview of research and development, manufacturing, outsourcing, and distribution trends, as well as infrastructure profiles for the leading pharmaceutical companies in Turkey.

Published By Datamonitor
29 Jun 2011 $1520
Buy
Report
Report

Turkey: Generics and Biosimilars Overview

Overview of the generics and biosimilars landscape including, regulatory issues, drivers and resistors to uptake, level of penetration, and key players operating in the market.

Published By Datamonitor
29 Jun 2011 $1520
Buy
Report
Report

CNS Market Access in India: Government investment into CNS services set to stimulate market growth

This report examines the CNS market in India. It reviews the epidemiology and treatment of key conditions. It also provides analysis of the strengths, weaknesses, opportunities and threats of the market and strategies for market penetration.

Published By Datamonitor
28 Jun 2011 $2800
Buy
Report
Report

Product Profiles: Systemic Lupus Erythematosus – Benlysta approval brings lessons and hope to market

Datamonitor’s survey of 108 US rheumatologists after the momentous approval of Benlysta (belimumab; Human Genome Sciences/GlaxoSmithKline) assesses its impact on the market. Additional pipeline products have moved into Phase III during the last year.

Published By Datamonitor
27 Jun 2011 $6400
Buy

« | ... | 352 | 353 | 354 | 355 | 356 | 357 | 358 | 359 | 360 | ... | » »|

No help is available.